• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两个氧化应激相关基因(血红素加氧酶-1 和 GSK3β)对帕金森病风险的协同作用。

Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3β) on the risk of Parkinson's disease.

机构信息

Neurology Service and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), "Marqués de Valdecilla" University Hospital (University of Cantabria), Santander, Spain.

出版信息

Eur J Neurol. 2010 May;17(5):760-2. doi: 10.1111/j.1468-1331.2009.02908.x. Epub 2009 Dec 21.

DOI:10.1111/j.1468-1331.2009.02908.x
PMID:20039940
Abstract

BACKGROUND

Oxidative stress is a central factor in the pathogenesis of Parkinson's disease (PD). Heme oxygenase-1 (HO-1) is an antioxidant protein expressed in response to oxidative challenge, and its expression levels are inversely correlated with glycogen synthase kinase-3beta (GSK3beta) activity. Underexpression of HO-1 in concert with an upregulation of GSK3beta would result in a less effective antioxidant response and might increase the risk of PD.

METHODS

We examined two functional polymorphism in the promoter regions of HO-1 (-413, rs2071746) and GSK3beta (-157, rs6438552) in a group of 251 Spanish patients with PD and 234 controls.

RESULTS

Subjects carrying both the HO-1 (-413, rs2071746) TT genotype and the GSK3beta (-157, rs6438552) TT genotype had a four times higher risk of developing PD than subjects without these genotypes (adjusted by age and sex OR = 4.12; 95% CI = 1.45-11.71; Bonferroni corrected P = 0.024).

CONCLUSIONS

Considering synergistic effects between polymorphisms in oxidative stress-related genes may help in determining the risk profile for PD.

摘要

背景

氧化应激是帕金森病(PD)发病机制的一个核心因素。血红素加氧酶-1(HO-1)是一种抗氧化蛋白,可响应氧化应激而表达,其表达水平与糖原合酶激酶-3β(GSK3β)活性呈负相关。HO-1 的表达下调与 GSK3β 的上调同时发生,将导致抗氧化反应不那么有效,并且可能增加 PD 的风险。

方法

我们在一组 251 名西班牙 PD 患者和 234 名对照中检查了 HO-1(-413,rs2071746)和 GSK3β(-157,rs6438552)启动子区域的两个功能多态性。

结果

与不携带这些基因型的受试者相比,同时携带 HO-1(-413,rs2071746)TT 基因型和 GSK3β(-157,rs6438552)TT 基因型的受试者患 PD 的风险高四倍(经年龄和性别调整的 OR = 4.12;95%CI = 1.45-11.71;Bonferroni 校正 P = 0.024)。

结论

考虑氧化应激相关基因多态性之间的协同作用可能有助于确定 PD 的风险特征。

相似文献

1
Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3β) on the risk of Parkinson's disease.两个氧化应激相关基因(血红素加氧酶-1 和 GSK3β)对帕金森病风险的协同作用。
Eur J Neurol. 2010 May;17(5):760-2. doi: 10.1111/j.1468-1331.2009.02908.x. Epub 2009 Dec 21.
2
Gene-gene interaction between heme oxygenase-1 and liver X receptor-beta and Alzheimer's disease risk.血红素加氧酶-1 和肝 X 受体-β 基因-基因相互作用与阿尔茨海默病风险。
Neurobiol Aging. 2010 Apr;31(4):710-4. doi: 10.1016/j.neurobiolaging.2008.05.025. Epub 2008 Jul 1.
3
GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort.GSK3β 多态性、MAPT H1 单倍型与希腊队列帕金森病的关系。
Neurobiol Aging. 2011 Mar;32(3):546.e1-5. doi: 10.1016/j.neurobiolaging.2009.05.007. Epub 2009 Jul 1.
4
Synergistic effect of heme oxygenase-1 and tau genetic variants on Alzheimer's disease risk.血红素加氧酶-1与tau基因变异对阿尔茨海默病风险的协同作用。
Dement Geriatr Cogn Disord. 2008;26(4):339-42. doi: 10.1159/000161059. Epub 2008 Oct 8.
5
GSK3β reduces risk of sporadic Parkinson's disease in ethnic Chinese.GSK3β 降低汉族人群散发性帕金森病的发病风险。
Am J Med Genet B Neuropsychiatr Genet. 2012 Sep;159B(6):718-21. doi: 10.1002/ajmg.b.32075. Epub 2012 Jul 19.
6
Heme oxygenase-1 promoter polymorphisms and risk of spina bifida.血红素加氧酶-1启动子多态性与脊柱裂风险
Birth Defects Res A Clin Mol Teratol. 2015 Sep;103(9):741-6. doi: 10.1002/bdra.23343. Epub 2015 Jul 15.
7
Genetic analysis of heme oxygenase-1 (HO-1) in German Parkinson's disease patients.德国帕金森病患者中血红素加氧酶-1(HO-1)的基因分析。
J Neural Transm (Vienna). 2009 Jul;116(7):853-9. doi: 10.1007/s00702-009-0237-6. Epub 2009 May 28.
8
GSK3B polymorphisms alter transcription and splicing in Parkinson's disease.糖原合成酶激酶3β基因多态性改变帕金森病中的转录和剪接。
Ann Neurol. 2005 Dec;58(6):829-39. doi: 10.1002/ana.20691.
9
NFE2L2 variations reduce antioxidant response in patients with Parkinson disease.NFE2L2基因变异降低帕金森病患者的抗氧化反应。
Oncotarget. 2016 Mar 8;7(10):10756-64. doi: 10.18632/oncotarget.7353.
10
Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors.血红素加氧酶-1基因启动子多态性与有冠心病危险因素的日本患者的冠状动脉疾病相关。
Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1680-5. doi: 10.1161/01.atv.0000033515.96747.6f.

引用本文的文献

1
Clearing the Smoke: What Protects Smokers from Parkinson's Disease?拨开迷雾:什么能保护烟民免受帕金森病困扰?
Mov Disord. 2024 Feb;39(2):267-272. doi: 10.1002/mds.29707. Epub 2024 Jan 16.
2
Punicalagin's Protective Effects on Parkinson's Progression in Socially Isolated and Socialized Rats: Insights into Multifaceted Pathway.石榴皮鞣质对社交隔离和社交化大鼠帕金森病进展的保护作用:对多方面途径的见解
Pharmaceutics. 2023 Oct 4;15(10):2420. doi: 10.3390/pharmaceutics15102420.
3
Neuroprotective Effects of Some Nutraceuticals against Manganese-Induced Parkinson's Disease in Rats: Possible Modulatory Effects on TLR4/NLRP3/NF-κB, GSK-3β, Nrf2/HO-1, and Apoptotic Pathways.
某些营养保健品对锰诱导的大鼠帕金森病的神经保护作用:对TLR4/NLRP3/NF-κB、GSK-3β、Nrf2/HO-1和凋亡途径的可能调节作用
Pharmaceuticals (Basel). 2022 Dec 14;15(12):1554. doi: 10.3390/ph15121554.
4
GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders.GSK-3β 介导的 Nrf2/HO-1 信号通路调节作为治疗运动障碍的新方法。
Pharmacol Rep. 2022 Aug;74(4):557-569. doi: 10.1007/s43440-022-00390-z. Epub 2022 Jul 26.
5
Heme Oxygenases: Cellular Multifunctional and Protective Molecules against UV-Induced Oxidative Stress.血红素加氧酶:细胞多功能和保护分子,抵御 UV 诱导的氧化应激。
Oxid Med Cell Longev. 2019 Nov 21;2019:5416728. doi: 10.1155/2019/5416728. eCollection 2019.
6
GSK-3 at the Intersection of Neuronal Plasticity and Neurodegeneration.GSK-3 在神经元可塑性和神经退行性变的交汇点。
Neural Plast. 2019 May 2;2019:4209475. doi: 10.1155/2019/4209475. eCollection 2019.
7
Inhibition of SIRT2 by Targeting GSK3β-Mediated Phosphorylation Alleviates SIRT2 Toxicity in SH-SY5Y Cells.通过靶向糖原合成酶激酶3β介导的磷酸化抑制沉默调节蛋白2可减轻其在SH-SY5Y细胞中的毒性
Front Cell Neurosci. 2019 Apr 24;13:148. doi: 10.3389/fncel.2019.00148. eCollection 2019.
8
Genetic polymorphism of the Nrf2 promoter region is associated with vitiligo risk in Han Chinese populations.Nrf2启动子区域的基因多态性与中国汉族人群的白癜风风险相关。
J Cell Mol Med. 2016 Oct;20(10):1840-50. doi: 10.1111/jcmm.12874. Epub 2016 May 25.
9
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism.Nrf2/HO-1系统在发育、氧化应激反应及疾病中的作用:一种进化保守机制
Cell Mol Life Sci. 2016 Sep;73(17):3221-47. doi: 10.1007/s00018-016-2223-0. Epub 2016 Apr 21.
10
Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Multiple Sclerosis.血红素加氧酶-1和2的常见基因变异与多发性硬化症风险
Sci Rep. 2016 Feb 12;6:20830. doi: 10.1038/srep20830.